© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to October
oral prostaglandin F receptor GCPR antagonist
to treat IPF, in vivo efficacy in fibrosis model
from ~3M cmpd cell-based HTS and opt.
J. Med. Chem., Oct. 22, 2020 issue
Bayer AG, Wuppertal, DE
BAY-6672 (Bayer oral in vivo prostaglandin F receptor GCPR antagonist)
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.